Revenue
$2.7B
▲ 8.3% YoY
Net Income
$47.0M
▲ 104.2% YoY
EPS
$0.28
▲ 104.3% YoY
Cash
$1.2B
▲ 13.3% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Acurio Veronica President, Orthodontics | Sell tax | Aug 25, 2026 | 7.7K | $27.47 | $212K | Form 4 ↗ |
Befidi Robert President, Diagnostics | Sell tax | Aug 25, 2026 | 5.1K | $27.47 | $141K | Form 4 ↗ |
Hammes Eric D. Chief Financial Officer | Sell tax | Aug 25, 2026 | 10.9K | $27.47 | $299K | Form 4 ↗ |
Nilsson Stefan President, Nobel Biocare | Sell tax | Aug 25, 2026 | 804 | $27.47 | $22K | Form 4 ↗ |
Reis Mischa SVP, Strategy & Bus. Dev. | Sell | Aug 20, 2026 | 8.0K | $27.50 | $220K | Form 4 ↗ |
Keel Paul A Chief Executive Officer | Grant | Aug 18, 2026 | 179.7K | $0.00 | $0 | Form 4 ↗ |